Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura.
Journal of thrombosis and haemostasis : JTH（2023）
摘要
gov as #NCT04985318.
更多查看译文
关键词
ADAMTS13 protein,observational study,purpura,thrombotic microangiopathies,thrombotic thrombocytopenic,von Willebrand factor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要